Humana Unrealized Gain (Loss) on Securities decreased by 163.1% to -$123.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 147.7%, from $258.00M to -$123.00M.
cop_unrealized_gain_loss_on_securities| Q3 '21 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$63.00M | -$623.00M | -$590.00M | $188.00M | -$137.00M | -$365.00M | -$114.00M | -$47.00M | $619.00M | $258.00M | $117.00M | $195.00M | -$123.00M |
| QoQ Change | — | -888.9% | +5.3% | +131.9% | -172.9% | -166.4% | +68.8% | +58.8% | >999% | -58.3% | -54.7% | +66.7% | -163.1% |
| YoY Change | — | — | -836.5% | — | +78.0% | +38.1% | -160.6% | +65.7% | +269.6% | +326.3% | +348.9% | -68.5% | -147.7% |